Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M deal
Source: news.google.com
Published: Jul 01, 2026 14:27
Source: news.google.com
Published: Jul 01, 2026 14:27
Related Stories
Clinical Trial of Shigella Vaccine Shows 89% Protection PR Newswire
#Clinical TrialsNext-generation HIF-2α inhibitor shows promise in kidney cancer translational clinical trial Medical Xpress
#Clinical TrialsClinical Trial of Shigella Vaccine Shows 89% Protection Research Horizons
#Clinical TrialsIdorsia names Roland Wandeler as CEO for next growth phase The Pharma Letter
#Biotech HeadlinesMore signs that GLP-1s may help with peripheral artery disease statnews.com
#Biotech HeadlinesBeeline Medicines closes upsized Series A financing The Pharma Letter
#Biotech HeadlinesAdd Shortcut
Open this site faster like an app from your phone home screen.